MedTrace Logo

Trial to Evaluate Efficacy and Safety of Combination of Diacerein and Celecoxib Administered in Patients With Knee OA

NCT03404479 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2018-02-26

No results posted yet for this study

Summary

The purpose of this study is to evaluate the pain relief effect of Co-administration of Diacerein with Celecoxib in patients with knee osteoarthritis compared with single administration of each drug.

Conditions

Interventions

DRUG

Diacerein

For 12 weeks, administered twice a day by oral.

DRUG

Celecoxib

For 12 weeks, administered twice a day by oral.

Sponsors & Collaborators

  • Korea University Guro Hospital

    collaborator OTHER

  • Whan-Seok Choi

    lead OTHER

Principal Investigators

  • Whan-Seok Choi, MD, PhD · Seoul St. Mary's Hospital

  • Seon-Mee Kim, MD, PhD · Korea University Guro Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-25
Primary Completion
2019-01-02
Completion
2019-01-02

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03404479 on ClinicalTrials.gov